<DOC>
	<DOCNO>NCT01327235</DOCNO>
	<brief_summary>The objective study compare efficacy Endostar/cisplatin cisplatin alone Endostar alone patient malignant pleural effusion ascites .</brief_summary>
	<brief_title>Endostar and/or Cisplatin Treatment Malignant Pleural Effusion Ascites</brief_title>
	<detailed_description />
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Ascites</mesh_term>
	<mesh_term>Pleural Effusion , Malignant</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Histological cytological diagnosis thoracic abdominal tumor At least medium amount malignant pleural effusion ascites ECOG Performance Status 02 Life expectancy â‰¥ 2 month Adequate hematologic , cardiac , renal , hepatic function No major surgery within 4 week prior study Written inform consent Patients central nervous system ( CNS ) metastases Evidence bleed diathesis , serious infection Evidence myocardial infarction , unstable angina cardiac insufficiency Presence serious COPD and/or respiratory failure Allergic study drug Pregnant lactate woman Participation clinical trial within 30 day prior study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>